GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
0.3771
-0.0065 (-1.69%)
At close: Dec 5, 2025, 4:00 PM EST
0.3801
+0.0030 (0.80%)
After-hours: Dec 5, 2025, 7:57 PM EST
GeoVax Labs Revenue
GeoVax Labs had revenue of $3.35M in the twelve months ending September 30, 2025, up 8.52% year-over-year. In the year 2024, GeoVax Labs had annual revenue of $3.95M.
Revenue (ttm)
$3.35M
Revenue Growth
+8.52%
P/S Ratio
1.75
Revenue / Employee
$197,268
Employees
17
Market Cap
11.20M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
GOVX News
- 22 days ago - GeoVax Labs, Inc. (GOVX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - GeoVax Labs Revenue Doubles in Q2 - The Motley Fool
- 4 months ago - GeoVax Labs, Inc. (GOVX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 months ago - GeoVax Labs, Inc. (GOVX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 9 months ago - GeoVax Labs, Inc. (GOVX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - GeoVax Receives Notice of Allowance For Cancer Vaccine Patent - GlobeNewsWire
- 1 year ago - GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference - GlobeNewsWire
- 1 year ago - GeoVax Labs, Inc. (GOVX) Q3 2024 Earnings Call Transcript - Seeking Alpha